Catalent

Catalent

World Rank (Jan-05-2024)
2,042
Market Cap (Jan-05-2024)
7.849 Billion USD
World Rank (Jul-30-2023)
1,886
Market Cap (Jul-30-2023)
8.686 Billion USD
World Rank (Jan-07-2022)
1,050
Market Cap (Jan-07-2022)
19.765 Billion USD
World Rank (Jan-01-2021)
1,045
Market Cap (Jan-01-2021)
17.140 Billion USD
Company Rank in Country in 2023
Rank in USA in July-2023 is 684
Headquarters Country
USA
Nasdaq / NYSE Code
CTLT
CEO
John Chiminski
Employee Count
19,000
Employee Count as of Date
As on 2022
Headquarters City/State
New Jersey
World Region
Americas
World Subregion
Northern America
Annual Revenue in USD
4,276 Million USD
Annual Operating Income in USD
73 Million USD
Annual Net Income in USD
-232 Million USD
Annual Results for Period Ending
Jun-2023 ending period
Total Assets in USD
10,782 Million USD
Total Liabilities in USD
6,147 Million USD
Total Equity in USD
4,635 Million USD
Balance Sheet for Period Ending
Jun-2023 ending period
Business Sector
Healthcare
HealthCare Products
Pharmaceutical
Company Website
CATALENT INC
Wikipedia
Wikipedia
Yahoo
Yahoo @ NYSE
Company Profile

CATALENT is Pharmaceutical company with headquarters is in New Jersey, USA.Catalent is the global leader in enabling pharma, biotech, and consumer health partners to optimize product development, launch, and full life-cycle supply for patients around the world.CATALENT manufacture oral, sterile and inhaled dose forms, produce biologics for pre-clinical and clinical studies.CATALENT pharmaceutical industry in the development and manufacturing of new treatments for patients worldwide.

As on 2021, CATALENT has 19,000 employees

CATALENT annual revenue generated for period ending Jun-2022 was 4,828 million USD.

CATALENT annual net income generated for period ending Jun-2022 was 503 million USD.

Total Assets as on Jun-2021 was 10,507 Million USD.

Annual Results Summary

CATALENT - Annual Result Summary - in Million USD

Year Ending:Total RevenueGross ProfitOperating IncomeNet Income
Jun-20234,2631,04047-256
Jun-20224,8281,640755503
Jun-20213,9981,352646529
Jun-20203,094983394221
Jun-20192,518805274137
Jun-20182,46375326984
Jun-20172,075655234110
Balance Sheet Summary

Total Assets as on Jun-2023 was 10,777 Million USD.

Total Liabilities as on Jun-2023 was 6,166 Million USD.

Total Equity as on Jun-2023 was 4,611 Million USD.

Founded Year
2007
IPO Year
2014
Stock Exchange
NYSE
Frankfurt
Company SubCategory
Top Healthcare Companies in USA
Nasdaq Sector
Health Care
Nasdaq Industry
Biotechnology: Pharmaceutical Preparations

Share